Cargando…

Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway

This study aimed to explore the effects of plumbagin on rheumatoid arthritis (RA) and its mechanism. The RA cell model was simulated following the treatment of interleukin-1β (IL-1β). After the treatment of various concentrations of plumbagin, the impact of plumbagin on the cell viability was examin...

Descripción completa

Detalles Bibliográficos
Autores principales: Shu, Chang, Chen, Jun, Lv, Meiyan, Xi, Yiyuan, Zheng, Jujia, Xu, Xiangwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276045/
https://www.ncbi.nlm.nih.gov/pubmed/35653787
http://dx.doi.org/10.1080/21655979.2022.2081756
_version_ 1784745630445338624
author Shu, Chang
Chen, Jun
Lv, Meiyan
Xi, Yiyuan
Zheng, Jujia
Xu, Xiangwei
author_facet Shu, Chang
Chen, Jun
Lv, Meiyan
Xi, Yiyuan
Zheng, Jujia
Xu, Xiangwei
author_sort Shu, Chang
collection PubMed
description This study aimed to explore the effects of plumbagin on rheumatoid arthritis (RA) and its mechanism. The RA cell model was simulated following the treatment of interleukin-1β (IL-1β). After the treatment of various concentrations of plumbagin, the impact of plumbagin on the cell viability was examined by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The collagen-induced arthritis (CIA) model was established using the solution of bovine type II collagen. Hematoxylin-eosin staining was used to observe the changes of ankle joint tissue, while enzyme-linked immunosorbent assay and western blot were applied to detect the level of inflammatory cytokines. Plumbagin inhibited the viability of human fibroblast-like synoviocytes (HFLS) at the concentration of 1 ~ 3.5 μM. The inhibitory effect of 1 μM plumbagin on cell proliferation was similar to that of methotrexate, the drug used as the positive control. Plumbagin downregulated the levels of inflammatory cytokines and matrix metalloproteinases (MMPs) in IL-1β-treated HFLS, and suppressed the activation of IκB and nuclear factor kappa-B (NF-κB) as well as the entry of p65 into the nucleus. It was also demonstrated in animal experiments that plumbagin inhibited the activation of NF-κB pathway, down-regulated the levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and MMPs, and alleviated joint damage in CIA-modeled mice. Collectively speaking, plumbagin might down-regulate the levels of inflammatory cytokines and MMPs through inhibiting the activation of the NF-κB pathway, thereby attenuating RA-induced damage to cells and joints. Abbreviations: CIA: Collagen-induced arthritis; ELISA: Enzyme-linked immuno sorbent assay; HFLS: Human fibroblast-like synoviocytes; IL-6: Interleukin-6; IL-1β: Interleukin-1β; NF-κB: nuclear factor kappa-B; MTT: 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; MMPs: Matrix metalloproteinase; OD: Optical density; RA: Rheumatoid arthritis; SDS: Sodium dodecyl sulfate; SD: Standard deviation; TNF-α: Tumor necrosis factor-α; PVDF: Polyvinylidene fluoride.
format Online
Article
Text
id pubmed-9276045
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-92760452022-07-13 Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway Shu, Chang Chen, Jun Lv, Meiyan Xi, Yiyuan Zheng, Jujia Xu, Xiangwei Bioengineered Research Paper This study aimed to explore the effects of plumbagin on rheumatoid arthritis (RA) and its mechanism. The RA cell model was simulated following the treatment of interleukin-1β (IL-1β). After the treatment of various concentrations of plumbagin, the impact of plumbagin on the cell viability was examined by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The collagen-induced arthritis (CIA) model was established using the solution of bovine type II collagen. Hematoxylin-eosin staining was used to observe the changes of ankle joint tissue, while enzyme-linked immunosorbent assay and western blot were applied to detect the level of inflammatory cytokines. Plumbagin inhibited the viability of human fibroblast-like synoviocytes (HFLS) at the concentration of 1 ~ 3.5 μM. The inhibitory effect of 1 μM plumbagin on cell proliferation was similar to that of methotrexate, the drug used as the positive control. Plumbagin downregulated the levels of inflammatory cytokines and matrix metalloproteinases (MMPs) in IL-1β-treated HFLS, and suppressed the activation of IκB and nuclear factor kappa-B (NF-κB) as well as the entry of p65 into the nucleus. It was also demonstrated in animal experiments that plumbagin inhibited the activation of NF-κB pathway, down-regulated the levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and MMPs, and alleviated joint damage in CIA-modeled mice. Collectively speaking, plumbagin might down-regulate the levels of inflammatory cytokines and MMPs through inhibiting the activation of the NF-κB pathway, thereby attenuating RA-induced damage to cells and joints. Abbreviations: CIA: Collagen-induced arthritis; ELISA: Enzyme-linked immuno sorbent assay; HFLS: Human fibroblast-like synoviocytes; IL-6: Interleukin-6; IL-1β: Interleukin-1β; NF-κB: nuclear factor kappa-B; MTT: 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; MMPs: Matrix metalloproteinase; OD: Optical density; RA: Rheumatoid arthritis; SDS: Sodium dodecyl sulfate; SD: Standard deviation; TNF-α: Tumor necrosis factor-α; PVDF: Polyvinylidene fluoride. Taylor & Francis 2022-06-02 /pmc/articles/PMC9276045/ /pubmed/35653787 http://dx.doi.org/10.1080/21655979.2022.2081756 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Shu, Chang
Chen, Jun
Lv, Meiyan
Xi, Yiyuan
Zheng, Jujia
Xu, Xiangwei
Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway
title Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway
title_full Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway
title_fullStr Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway
title_full_unstemmed Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway
title_short Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway
title_sort plumbagin relieves rheumatoid arthritis through nuclear factor kappa-b (nf-κb) pathway
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276045/
https://www.ncbi.nlm.nih.gov/pubmed/35653787
http://dx.doi.org/10.1080/21655979.2022.2081756
work_keys_str_mv AT shuchang plumbaginrelievesrheumatoidarthritisthroughnuclearfactorkappabnfkbpathway
AT chenjun plumbaginrelievesrheumatoidarthritisthroughnuclearfactorkappabnfkbpathway
AT lvmeiyan plumbaginrelievesrheumatoidarthritisthroughnuclearfactorkappabnfkbpathway
AT xiyiyuan plumbaginrelievesrheumatoidarthritisthroughnuclearfactorkappabnfkbpathway
AT zhengjujia plumbaginrelievesrheumatoidarthritisthroughnuclearfactorkappabnfkbpathway
AT xuxiangwei plumbaginrelievesrheumatoidarthritisthroughnuclearfactorkappabnfkbpathway